Technology area: Medical Devices & Mechanical Engineering
3 pending office actions • 2 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready
Microsurgical Technology Inc. currently has 3 pending office actions within the Medical Devices & Mechanical Engineering technology area. These actions are being handled by 3 distinct examiners across 2 distinct art units. The busiest examiner, MEDWAY, SCOTT J, is assigned 1 busiest examiner pending action. This distribution shows that the current workload is spread evenly among the 3 distinct examiners, with no single examiner handling more than one action.
The 3 pending office actions are concentrated within 2 distinct art units, suggesting some overlap in the technical classification of the applications. However, because there are 3 distinct examiners, the company must manage three different individual approaches to prosecution. MEDWAY, SCOTT J, despite being the busiest examiner, only holds 1 busiest examiner pending action, which matches the distribution of the workload across the assigned examiners. This spread across the 2 distinct art units requires a coordinated effort to ensure consistency.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §102 only | 1 (33%) |
| §112 only | 1 (33%) |
| Multi-statute (no §101) | 1 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| RASSAVONG, ERIC | 1 | 71.6% | +34.4% |
| MEDWAY, SCOTT J | 1 | 66.7% | +23.4% |
| FLICK, JASON E | 1 | 80.6% | +13.4% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17409228 | INTRAOCULAR IRRIGATOR-ASPIRATOR TIP COMPONENT | FLICK, JASON E | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18026996 | GONIOTOMY DEVICES WITH FLUID INGRESS/EGRESS CONTROL | RASSAVONG, ERIC | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18026941 | FLUIDICS CONTROL FOR MICROSURGICAL DEVICES | MEDWAY, SCOTT J | 156d overdue |
| 18026996 | GONIOTOMY DEVICES WITH FLUID INGRESS/EGRESS CONTROL | RASSAVONG, ERIC | — |
| 17409228 | INTRAOCULAR IRRIGATOR-ASPIRATOR TIP COMPONENT | FLICK, JASON E | — |
| Art Unit | Apps |
|---|---|
| 3783 | 2 |
| 3781 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18026996 | GONIOTOMY DEVICES WITH FLUID INGRESS/EGRESS CONTROL | RASSAVONG, ERIC | 3781 | §102§103§112 | Non-Final OA | — | Pending | Mar 17, 2023 |
| 18026941 | FLUIDICS CONTROL FOR MICROSURGICAL DEVICES | MEDWAY, SCOTT J | 3783 | §102 | Non-Final OA | 156d overdue | Pending | Mar 17, 2023 |
| 17409228 | INTRAOCULAR IRRIGATOR-ASPIRATOR TIP COMPONENT | FLICK, JASON E | 3783 | §112 | Non-Final OA | — | Pending | Aug 23, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial